LIS1

N/A

Report date: 2023/03/05 16:37:29

Base Information

Drug NameLIS1
Drug Alias NameHeterologous swine glyco-humanised polyclonal antibody against T lymphocytes (Xenothera)LIS1
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionImmunosuppressants
TargetsNot applicable
Therapy Area/IndicationsRejection of renal transplantationLymphoma, T-Cell, Peripheral
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaItalyFrance
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesXenothera Sas
China Registration ClassN/A

Develop Information

Active CompaniesXenothera Sas
Inactive CompaniesN/A
Active IndicationsRejection of renal transplantationLymphoma, T-Cell, Peripheral
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A